1) benign tertian malaria
良性间日疟
2) malignant tertian malaria
恶性间日疟
3) therapeutic vivax malaria
治疗性间日疟
4) Plasmodium vivax malaria
间日疟
1.
Proportion variation of NK,γδ T and Treg cells in peripheral blood of Plasmodium vivax malaria patients;
间日疟患者外周血NK γδ T Treg细胞含量的变化
2.
Cytokine responese of HIV-positive patients to acute Plasmodium vivax malaria;
HIV阳性患者感染急性间日疟的细胞因子反应
3.
Objective:To observe the clinical therapeutic efficacies of complex naphthoquine and chloroquine in patients with Plasmodium vivax malaria.
目的 :观察复方萘酚喹与氯喹治疗间日疟的临床疗效。
5) Vivax malaria
间日疟
1.
Theory of hypnozoite and progress of studies on radical treatment of vivax malaria
间日疟的复发及治疗研究现状
6) Plasmodium vivax
间日疟
1.
Design, Synthesis and Expression of A Multi-Epitope Gene of Plasmodium vivax;
间日疟原虫多表位疫苗基因的设计、合成与酵母表达
2.
Results The sensitivity and specificity of OptiMAL assay for detection of Plasmodium vivax malaria were 59% (95%CI:0.
结果检测间日疟的敏感度为59%(95%CI0。
补充资料：良性
①能产生好的结果的：～循环。②不至于产生严重后果的：～肿瘤。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条